CT-Plaque Vulnerability Index (Low-Attenuation Plaque %) Calculator

Clinical calculation support · Verify results before clinical use

Plaque Volume Assessment

Enter CCTA plaque measurements. Use vessel volume or a validated direct LAP-burden measurement for comparison with the SCOT-HEART threshold.

—LAP burden
Used to calculate the proportion of low-attenuation plaque within total plaque volume. This proportion is not the SCOT-HEART LAP burden.
LAP is commonly defined as plaque voxels with attenuation <30 HU in the cited SCOT-HEART analyses.
If supplied, LAP burden is calculated as LAP volume ÷ vessel volume × 100, matching the vessel-volume denominator used in SCOT-HEART quantitative plaque analyses.
The ≥4% increased-burden rule is only displayed when the threshold is 30 HU and a valid vessel-volume-based burden or direct burden is available.
Enter a validated per-patient LAP burden (%) calculated by your CCTA analysis software. If entered, this takes precedence for SCOT-HEART threshold and research HR display.

Clinical Context and Calculation

Low-attenuation non-calcified plaque on coronary CT angiography is associated with subsequent myocardial infarction. In the SCOT-HEART analysis, LAP was defined using an attenuation threshold below 30 Hounsfield units (HU), and quantitative plaque burden was calculated relative to the vessel volume of the assessed region.

Calculations used

  • LAP as a proportion of total plaque (%) = LAP volume ÷ total plaque volume × 100.
  • Vessel-volume LAP burden (%) = LAP volume ÷ assessed vessel volume × 100.
  • Research relative HR vs. 1% burden = 1.60log2(burden / 1%), shown only when a vessel-volume-based or directly entered burden is available and positive.
Important denominator distinction: LAP volume divided by total plaque volume is a plaque-composition proportion. It is not interchangeable with the SCOT-HEART LAP burden, which uses vessel volume as the denominator. Therefore, the 4% threshold and published hazard estimates must not be applied to the total-plaque proportion.

Interpretation and limitations

In the SCOT-HEART cohort, LAP burden >4% was associated with a higher subsequent MI risk (HR 4.65; 95% CI 2.06–10.5), while each doubling of LAP burden was associated with an adjusted HR of 1.60 (95% CI 1.10–2.34). These estimates were derived in patients presenting with stable chest pain and should not be interpreted as a patient-specific probability of MI.

Quantification depends on CCTA acquisition, image quality, segmentation, software, and the exact region assessed. The calculator does not independently segment images or validate measurements. Use the analysis method and denominator defined by the source study/software when comparing values.

References

Williams MC, Kwiecinski J, Doris M, et al.Low-Attenuation Noncalcified Plaque on Coronary Computed Tomography Angiography Predicts Myocardial Infarction: Results From the Multicenter SCOT-HEART Trial. Circulation. 2020;141(18):1452–1462. DOI: 10.1161/CIRCULATIONAHA.119.044720; PMID: 32174130.
Williams MC, Moss AJ, Dweck M, et al.Coronary Artery Plaque Characteristics Associated With Adverse Outcomes in the SCOT-HEART Study. J Am Coll Cardiol. 2019;73(3):291–301. Article: full text at PubMed Central.
Clinical disclaimer: This tool is intended for educational and research support. It does not replace expert CCTA interpretation, validated quantitative plaque-analysis software, or clinical judgement. The SCOT-HEART risk associations are not an absolute-risk calculator and should not be used alone to determine management.